tiprankstipranks
Advertisement
Advertisement

MCRB Stock Latest News

Seres Therapeutics announces three presentations at 2026 ESCMID congress
The FlySeres Therapeutics announces three presentations at 2026 ESCMID congress
20d ago
MCRB
Seres Therapeutics announces three presentations at 2026 ESCMID congress
PremiumThe Fly
Seres Therapeutics announces three presentations at 2026 ESCMID congress
20d ago
MCRB
Seres Therapeutics Sets 2026 Annual Shareholder Meeting Date
PremiumCompany Announcements
Seres Therapeutics Sets 2026 Annual Shareholder Meeting Date
2M ago
8K
MCRB
Seres Therapeutics Reports 2025 Results, Highlights Refocused Pipeline
PremiumCompany Announcements
Seres Therapeutics Reports 2025 Results, Highlights Refocused Pipeline
2M ago
8K
MCRB
Seres Therapeutics reports FY25 EPS 64c
PremiumThe Fly
Seres Therapeutics reports FY25 EPS 64c
2M ago
MCRB
Is MCRB a Buy, Before Earnings?
PremiumPre-EarningsIs MCRB a Buy, Before Earnings?
2M ago
MCRB
Seres Therapeutics Announces Executive Leadership Changes and Promotions
Premium
Company Announcements
Seres Therapeutics Announces Executive Leadership Changes and Promotions
2M ago
8K
MCRB
Seres co-CEOs Tom DesRosier, Marella Thorell to step down
Premium
The Fly
Seres co-CEOs Tom DesRosier, Marella Thorell to step down
2M ago
MCRB
Seres pauses investment in SER-155 program, reports workforce reduction of 30%
PremiumThe Fly
Seres pauses investment in SER-155 program, reports workforce reduction of 30%
3M ago
MCRB
Seres announces publications in Nature Medicine, Journal of Infectious Diseases
PremiumThe Fly
Seres announces publications in Nature Medicine, Journal of Infectious Diseases
4M ago
MCRB
Seres Therapeutics Reports Positive Q3 2025 Results
PremiumCompany Announcements
Seres Therapeutics Reports Positive Q3 2025 Results
6M ago
MCRB
Seres Therapeutics Reports Positive Q3 Earnings Call
PremiumCompany Announcements
Seres Therapeutics Reports Positive Q3 Earnings Call
6M ago
MCRB
Seres Therapeutics Reports Q3 Results and Business Updates
PremiumCompany AnnouncementsSeres Therapeutics Reports Q3 Results and Business Updates
6M ago
8K
MCRB
Seres Therapeutics reports Q3 EPS 94c vs ($6.69) last year
Premium
The Fly
Seres Therapeutics reports Q3 EPS 94c vs ($6.69) last year
6M ago
MCRB
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MCRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
MCRB
Seres Therapeutics receives award of up to $3.6M from CARB-X
PremiumThe Fly
Seres Therapeutics receives award of up to $3.6M from CARB-X
6M ago
MCRB
Seres Therapeutics to present new post hoc data from SER-155 Phase 1b trial
PremiumThe Fly
Seres Therapeutics to present new post hoc data from SER-155 Phase 1b trial
7M ago
MCRB
Seres Therapeutics Cuts Costs to Extend Cash Runway
PremiumCompany Announcements
Seres Therapeutics Cuts Costs to Extend Cash Runway
7M ago
8K
MCRB
Seres Therapeutics price target raised to $22 from $14 at Canaccord
PremiumThe Fly
Seres Therapeutics price target raised to $22 from $14 at Canaccord
8M ago
MCRB
Seres Therapeutics announces further constructive feedback from FDA on SER-155
PremiumThe FlySeres Therapeutics announces further constructive feedback from FDA on SER-155
8M ago
MCRB
Seres Therapeutics’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Seres Therapeutics’ Earnings Call: Progress Amid Challenges
9M ago
MCRB
Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
Premium
Ratings
Promising Developments and Strategic Partnerships Drive Buy Rating for Seres Therapeutics
9M ago
MCRB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >